The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion

Journal of Molecular Biology

Volumn 274, Issue 3, 1997, Pages 381-393

  Pillot, Thierry ^c   Lins, Laurence ^a   Goethals, Marc ^b   Vanloo, Berlinda ^c   Baert, Johan ^c   Vandekerckhove, Joel ^b   Rosseneu, Maryvonne ^c   Brasseur, Robert ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c NONE

Author keywords

Amyloid fibrils; Membrane fusion; Prion protein; Synthetic peptide; helix

Indexed keywords

AMYLOID; CALCEIN; LIPOSOME; PRION PROTEIN; SYNTHETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HYDROPHOBICITY; LIPID BILAYER; LIPID VESICLE; MEMBRANE FUSION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN LIPID INTERACTION;

EID: 0031555486     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.1382     Document Type: Article

References (33)

1. 2+ interaction with Alzheimer amyloid β protein calcium channels. Proc. Natl Acad. Sci. USA, 93, 1710-1715.
2. Brasseur, R. (1991). Differentiation of lipid-associating helices by use of three-dimensional molecular hydrophobicity potential calculation. J. Biol. Chem. 266, 16120-16127.
3. Brasseur, R., De Meutter, J., Vanloo, B., Goormaghtigh, E., Ruysschaert, J. M. & Rosseneu, M. (1992). Mode of assembly of amphipathic helical segments in model high density lipoproteins. Biochim. Biophys. Acta, 1043, 245-252.
4. Brasseur, R., Vanloo, B., Deleys, B., Lins, L., Labeur, C., Taveirne, J., Ruysschaert, J. M. & Rosseneu, M. (1993). Design and properties of synthetic model peptides for the amphipathic helices of plasma apolipoproteins. Biochim. Biophys. Acta, 1170, 1-7.
5. Brasseur, R., Pillot, T., Lins, L., Vandekerckhove, J. & Rosseneu, M. (1997). Peptides in membrane: tipping the balance of membrane stability. Trends Biochem. Sci. 22, 167-171.
6. Brown, D. R., Schmidt, B. & Kretzschmar, H. A. (1996). Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature, 380, 345-347.
7. Chen, S. G., Teplow, D. B., Parchi, P., Teller, J. K., Gambetti, P. & Autilio-Gambetti, L. (1995). Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270, 19173-19180.
8. Come, J. H., Fraser, P. E. & Lansbury, P. T. (1993). A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA, 90, 5959-5963.
9. Defrise-Quertain, F., Cabiaux, V., Vandenbranden, M., Wattiez, R., Falmagne, P. & Ruysschaert, J. M. (1989). pH-dependent bilayer destabilization and fusion of phospholipidic large unilamellar vesicles induced by diphteria toxin and its fragments A and B. Biochemistry, 28, 3406-3413.
10. Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H. & Lansbury, P. T. (1995). Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl Acad. Sci. USA, 92, 763-767.
11. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O. & Tagliavini, F. (1993). Neurotoxicity of a prion protein fragment. Nature, 362, 543-546.
12. Gray, C., Tatulian, S. S., Wharton, S. A. & Tamm, L. K. (1996). Effect of the N-terminal glycine on the secondary structure, orientation of the influenza hemagglutinin fusion peptide with lipid bilayers. Biophys J. 70, 2275-2286.
13. Heller, J., Kolbert, A. C., Larser, R., Ernst, M., Bekker, T., Baldwin, M. A., Prusiner, S. B., Pines, A. & Wemmer, D. E. (1996). Solid-state NMR studies of the prion protein H1 fragment. Protein Sci. 5, 1655-1661.
14. Horth, M., Lambrecht, B., Chuah Lay Khim, M., Bex, M., Thiriart, C., Ruysschaert, J.-M., Burny, A. & Brasseur, R. (1991). Theoretical and functional analysis of the SIV fusion peptide. EMBO J. 10, 2747-2755.
15. Huang, Z., Prusiner, S. B. & Cohen, F. E. (1995). Scrapie prions: a three-dimensional model of an infectious fragment. Folding Design, 1, 13-19.
16. Jarrett, J. T. & Lansbury, P. T. (1993). Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell, 73, 1055-1058.
17. Johnson, W. C., Jr (1990). Protein secondary structure and circular dichroism: a practical guide. Proteins: Struct. Funct. Genet. 7, 205-214.
18. Kendall, D. A. & McDonald, R. C. (1982). A fluorescence assay to monitor vesicle fusion and lysis. J. Biol. Chem. 257, 13892-13895.
19. Lambert, G., Decout, A., Vanloo, B., Rouy, D., Duverger, N., Kalopissis, A., Vandekerckhove, J., Chambaz, J., Brasseur, R. & Rosseneu, M. (1997). The C-terminal helix of human apolipoprotein A-II promotes the fusion of unilamellar liposomes and displaces apolipoprotein A-I from high density lipoproteins. Biochemistry. In the press.
20. Lehman, S. & Harris, D. A. (1996). Mutant and infectious prion proteins display common biochemical properties in cultured cells. J. Biol. Chem. 271, 1633-1637.
21. LeVine, H. (1993). Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2, 404-410.
22. Lin, M. X., Mirzabekov, T. & Kagan, B. L. (1997). Channel formation by a neurtoxic prion protein fragment. J. Biol. Chem. 272, 44-47.
23. Morris, S. J., Bradley, D., Gibson, C. C., Smith, P. D. & Blumenthal, R. (1988). Use of membrane-associated fluorescence probes to monitor fusion of bilayer vesicles: application to rapid kinetics using pyrene excimer/monomer fluorescence. In Spectroscopic Membrane Probes (Loem, L. M., ed.), pp. 161-191, CRC Press, Boca Raton, USA.
24. Oesch, B., Jensen, M., Nilsson, P. & Fogh, J. (1994). Properties of the scrapie prion protein: quantative analysis of protease resistance. Biochemistry, 33, 5926-5931.
25. 27-30 is a normal soluble prion protein fragment released by human platelets. Biochem. Biophys. Res. Commun. 223, 572-577.
26. Pillot, T., Goethals, M., Vanloo, B., Talussot, C., Brasseur, R., Rosseneu, M., Vandekerckhove, J. & Lins, L. (1996). Fusogenic properties of C-terminal domains of the Alzheimer beta-amyloid peptide. J. Biol. Chem. 271, 28757-28765.
27. Pillot, T., Brasseur, R., Vandekerchove, J. & Rosseneu, M. (1997). Apolipoprotein E inhibits liposome fusion induced by the Alzheimer's beta-amyloid peptide. Nutr. Metab. Cadiovasc. Dis. 7, 276-280.
28. Prusiner, S. B. (1994). Inherited prion diseases. Proc. Natl Acad. Sci. USA, 91, 4611-4614.
29. Rapaport, D. & Shai, Y. (1994). Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai Virus with phospholipid membranes. J. Biol. Chem. 269, 15124-15131.
30. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R. & Wüthrich, K. (1996). NMR structure of the mouse prion protein domain PrP (121-231). Nature, 382, 180-182.
31. Rizzardini, M., Chiesa, R., Angeretti, N., Lucca, E., Salmona, M., Forloni, G. & Cantoni, L. (1997). Prion protein fragment 106-126 differentially induces heme oxygenase I mRNA in cultured neurons and astroglial cells. J. Neurochem. 68, 715-720.
32. Wood, S. J., Maleeff, B., Hart, T. & Wetzel, R. (1996). Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ. J. Mol. Biol. 256, 870-877.
33. Zimmerberg, J., Vogel, S. S. & Chernomordik, L. V. (1993). Mechanism of membrane fusion. Annu. Rev. Biophys. Biomol. Struct. 22, 433-466.